WINTWINDTREE THERAPEUTICS INC /DE/

Nasdaq windtreetx.com


$ 3.23 $ -4.92 (-60.67 %)    

Tuesday, 03-Sep-2024 15:59:55 EDT
QQQ $ 461.29 $ -14.46 (-3.04 %)
DIA $ 410.26 $ -5.96 (-1.43 %)
SPY $ 551.70 $ -11.60 (-2.06 %)
TLT $ 97.57 $ 1.26 (1.31 %)
GLD $ 230.29 $ -1.00 (-0.43 %)
$ 3.19
$ 7.36
$ 7.56 x 100
-- x --
$ 3.23 - $ 7.36
$ 2.81 - $ 27.00
453,608
na
1.89M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-29-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-13-2020 03-31-2020 10-Q
19 04-03-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-20-2019 03-31-2019 10-Q
23 04-16-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-21-2018 03-31-2018 10-Q
27 04-17-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-21-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-12-2016 03-31-2016 10-Q
35 03-29-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 windtree-therapeutics-files-for-resale-of-up-to-107m-shares-by-the-selling-stockholder

 - SEC Filing

 windtree-therapeutics-q2-2024-gaap-eps-2091-misses-227-estimate

Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(20.91) per share which missed the analyst consensus estimate...

 wint---analyzing-windtree-therapeuticss-short-interest

Windtree Therapeutics's (NYSE:WINT) short percent of float has fallen 17.46% since its last report. The company recently r...

 why-windtree-therapeutics-wint-stock-is-volatile-today

Windtree Therapeutics shares are trading lower by 8.6% during Monday's session. The company announced it entered a $1M priv...

 on-july-26-2024-windtree-therapeutics-entered-into-a-securities-purchase-agreement-with-a-buyer-for-a-private-placement-of-1250-series-c-convertible-preferred-shares-and-warrants-for-up-to-267380-shares-of-common-stock-for-about-1m-in-gross-proceeds

- SEC Filing

 whats-going-on-with-windtree-therapeutics-stock

Windtree Therapeutics shares are racing higher Friday after the company requested the withdrawal of its Registration Statement ...

Core News & Articles
Market-Moving News for July 26th
07/26/2024 12:22:35

CREV: 136% | Reported Earlier, Carbon Revolution Teams Up With GM Providing Carbon Fiber Wheels For Chevrolet Corvette ZR1 WINT...

 windtree-therapeutics-provides-update-on-istaroxime-clinical-development-and-business-development

Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on ...

 windtree-therapeutics-on-june-26-2024-enters-common-stock-purchase-agreement-with-an-equity-line-investor---filing

The Company has the right, but not the obligation, to sell to the Purchaser, and the Purchaser is obligated to purchase, up to ...

 windtree-therapeutics-regains-compliance-with-nasdaq

Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on ...

 why-windtree-therapeutics-wint-stock-is-getting-hammered

Windtree Therapeutics shares are trading lower by 30% during Thursday's session. The company announced it approved a 1-for-...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION